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This paper summarises evidence relating to key issues surrounding e-cigarettes. It will be updated as new 
information emerges. Updated versions are made available on www.smokinginengland.info 
Safety: E-cigarettes are much less harmful than smoking but not 100% safe 
1. From the concentrations of potentially harmful inhalants in vapour, e-cigarette use from brands that 
have been tested so far would be expected much less harmful to health than smoking tobacco 
cigarettes (1-3). Well publicised reports of potential harmfulness of e-cigarette vapour have typically 
not compared this with tobacco cigarettes and/or have set up unrealistic conditions, e.g. (4). The 
precise extent of harm from long-term use is not known but from the toxicological evidence to date it 
would be expected to be 95% less than that of smoking tobacco cigarettes (5). 
2. Case reports suggest that a small proportion (estimated at less than 1/100,000) of e-cigarette users 
appear to suffer from serious though reversible  acute adverse reactions to the vapour (5). 
3. A substantial minority of e-cigarette users experience minor adverse reactions to the vapour 
(predominantly dry throat) (5). 
4. Cases of poisoning from consuming the nicotine liquid from e-cigarettes have been reported; so far one 
unconfirmed case of fatal poisoning in a small child has been reported by media and one case of fatal 
poisoning in an adult drinking estimated 10,800 mg of nicotine has been documented (6). 
5. Several cases of the lithium-ion battery in an e-cigarette ‘exploding’ has been reported; the rate of such 
events is estimated at less than 1 per million e-cigarettes sold (5, 6)  
6. The vapour exhaled by e-cigarette users contains chemicals such as nicotine which are below 
concentrations expected to cause significant harm to health of bystanders (5). 
Use among never-smokers: Use of e-cigarettes by never smokers is rare in the UK and US 
7. US surveys suggest there has been an increase in experimentation and recent (past 30-day) use by 
never smokers in recent years (7-9). However, there is no evidence of regular use by never smokers (7). 
8. Surveys of 11-14 year olds in Britain have shown 1-2% of never smokers have tried e-cigarettes in 2013, 
with almost no never smokers reporting current use (10, 11). 
9. In England, prevalence of e-cigarette current use among never smokers aged 16+ is currently 0.2% 
which is similar to use of licensed nicotine products (12).  
10. In the UK and US, the proportion of adolescents who smoke traditional cigarettes has continued to 
decline at least as fast as previously making it unlikely that e-cigarettes are acting as a gateway into 
smoking at a population level (13, 14). 
Use among smokers: Use of e-cigarettes is common (10-20%) but in England it has not increased over the 
past 12 months   
11. Surveys in different countries have put prevalence of current e-cigarette use among smokers at 10-20% 
(5); prevalence in England is currently 18% and has not increased since the third quarter of 2013. In the 
final quarter of 2014 there was a reduction in prevalence of e-cigarette use among people continuing 
to smoke conventional cigarettes (12) 
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12. In England (which has the most comprehensive data)  nearly 30% of attempts to stop smoking in the 
past year have involved e-cigarettes (12). This is higher than use of any other aid to cessation. 
13. The most common reason for using e-cigarettes is to reduce health risks of smoking (by stopping 
smoking completely and or reducing smoking) (15, 16). 
Product types: E-cigarettes vary widely in appearance and nicotine delivery 
14. There are a wide variety of e-cigarettes currently being used ranging from those that look like 
cigarettes to ones that bear little resemblance to cigarettes; the characteristics of these devices differ 
markedly, appealing to different types of smokers; most appear to deliver lower nicotine doses than 
from smoking but some e-cigarette users can obtain doses of nicotine similar to those typically found 
with smoking (5, 17) 
Effect on attempts to stop smoking: The advent of e-cigarettes does not appear to have had a major impact 
on quit attempt rates  
15. Smokers who currently also use e-cigarettes are more likely to have tried to stop in the recent past than 
those who have not used either e-cigarettes or a licensed nicotine product (5, 16) The growth in e-
cigarette prevalence in England has been accompanied by a very small increase in the rate at which 
smokers try to stop smoking, though this may be due to other factors (12) 
Effectiveness as an aid to smoking cessation: Use of e-cigarettes in a quit attempt is associated with 
increased abstinence rates compared with using no aid or licensed nicotine product bought from a store or 
placebo (nicotine-free) e-cigarettes 
16. Smokers in England who use e-cigarettes in a quit attempt are approximately 50% more likely to remain 
abstinent from cigarettes for at least a few months than those who try to quit unaided or using a 
licensed nicotine product bought from a store, but probably less likely than those who attend high 
quality specialist stop-smoking support of the kind available in England (18). This may mask marked 
individual differences in chances of success with different methods. 
17. Randomised controlled trials of now obsolete e-cigarettes in the context of some professional support 
suggest that those had a significant effect on cessation compared to placebo (e-cigarettes without 
nicotine) and had broadly similar levels of efficacy to licensed nicotine replacement products (19). 
18. The increase in e-cigarette use to aid quitting in England has been associated with an increase in the 
population smoking cessation rate, though this could be due to other factors (12). 
Effect of use while continuing to smoke: Use of e-cigarettes while smoking appears to be associated with a 
small reduction in cigarette consumption; its effect on subsequent smoking cessation is not clear 
19. Despite studies purporting to show that dual e-cigarette use and smoking may reduce the probability of 
future smoking cessation, e.g. (20), these do not address the issue, which has yet to be resolved. 
20. Smokers who use e-cigarettes smoke slightly fewer cigarettes than when they did not use them (21). In 
two RCTs smokers allocated to e-cigarettes were more likely to reduce their cigarette consumption by 
50% or more than smokers allocated to placebo e-cigarette or to nicotine patches (5) 
User groups: There are highly active e-cigarette user groups who oppose highly restrictive regulation 
21. There are several active e-cigarette user groups with enthusiastic advocates who share information 
about products and techniques for use, and argue to protect e-cigarette use against regulation that is 
as, or more, restrictive than regulation of cigarettes. 
Marketing: E-cigarettes are being strongly promoted using the full range of marketing tools, with some 
branding and imagery being similar to that currently or previously used for conventional cigarettes 
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A wide range of marketing approaches are being used in the UK; at least some of the advertising and 
branding has resembled that previously used for cigarettes (22, 23) but this should no longer be permitted 
under new regulations by the Advertising Standards Authority.  
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